Potassium is one of the major regulators of mineral corticoid function in the adrenal cortex. The response to potassium is associated with a rapid increase in aldosterone secretion. On the other hand, K + is known as principal regulator of apoptosis in the adrenal and other tissues [1] [2] [3] . Although K + stimulates an increase in cAMP formation and cAMP-dependent protein kinase A [4] , other secondary messengers including protein kinase C (PKC) [5, 6] , Ca 2+ -calmodulin-dependent protein kinase [7] are also activated by potassium. Stimuli that involve PKC and Ca
2+
-calmodulin dependent protein kinase also induce members of the mitogenactivated protein kinase (MAPK) family of serine/ threonine kinases [2] . MAPK include c-Jun Nterminal kinase (JNK), p42/p44 ERK1/2 (extracellular signal-regulated kinase) and p38 kinase. These serine/threonine kinases activate downstream transcription factors, which in turn induce expression of target genes. The transcription factors c-Jun, c-Fos, NF-kB were stimulated by K + in different types of cells [8, 9, 10] . Effects of K + differ in normal and tumor adrenocortical tissues. It was shown that the adrenal tumor tissue is less sensitive to proapoptotic action of potassium [1] .
Abstract. Potassium ions play an important role in the regulation of steroidogenesis, water-salt balance, apoptosis, proliferation. However, the nuclear phase of the agonist signaling in adrenocorticocytes remains poorly understood. The aim of the work was to elucidate the effect of potassium on the level of nuclear transcription factor c-Fos in human tumor adrenocortical tissue (aldosteroma). Methods. Expression of c-Fos transcription factor in aldosteromas was detected using Western-blot analysis. Results. The increase of c-Fos level in human aldosteroma cells at potassium physiological concentration of 3.5 mmol/l compared to medium without potassium was observed. The level of cFos did not change after 8.5 mmol/l K + administration. The possible participation of transcription factor c-Fos in steroidogenic effects of K + is being discussed. Conclusions. The results of study suggest that K + can have a direct effect on the expression level of nuclear transcription factor c-Fos in tissues from human aldosteromas. Keywords: К + , human adrenocorticocytes, aldosteroma, transcription factors. camera, scanned using «Gel Pro Analyzer» v. 4.0 software. Statistics. All data were expressed as a mean ±M. Differences between groups were examined for statistical significance using Student's t-test. Р<0.05 denoted the presence of a statistically significant difference.
Results and discussion
Activity of MAPK and its downstream transcription factors was associated with apoptotic or proliferative processes [13] . In addition it was suggested that this cascade kinases participate in the gluco-and mineralocorticoids biosynthesis regulation [14, 15] . c-Fos is one of the main transcription factor activated by MAPK. To study the effect of K + on transcription factor cFos expression and activation, Western blotting of the proteins from tissue of the human adrenal cortex tumor (aldosteroma) incubated at different potassium concentrations was performed. The decrease of K + concentration in incubation medium from basal, physiological 3.5 mmol/l to 0 causes 1.3-fold decrease of c-Fos quantity ( Fig. 1,  2) . Rise of potassium content to 8.5 mmol/l -the concentration that stimulates steroidogenesis under normal conditions -did not change the cFos level after 30 min of incubation ( Fig. 1, 2) .
There are no reports in the literature on changes in the level of the nuclear transcription factors under the influence of potassium ions on the adrenocortical tissue. However, the participation of the c-Jun factor in the potassium effect implementation was shown on cerebral neurons. Potassium increased the level of c-Jun protein in the cells and also accelerated the formation of the transcription factor AP-1 as a homodimer comThe aim of this work was to elucidate the effect of potassium in the human tumor adrenocortical tissue on the level of MAPK-dependent transcription factor cFos.
Materials and methods
Material. All the salts were provided by Merck (Germany); Tween 20 -by Ferak (Germany); HEPES, BSA (V fraction, content of lipids less than 0.1%) -by Serva (Germany). Lysis buffer, primary and secondary antibodies for c-Fos, β-actin by Cell Signaling Technology and Sigma (USA). The rest of reagents were obtained from local suppliers.
Tissue. The study was approved by the Institute's Ethics Committee. Effects of potassium ion were studied in tumor tissue (aldosteromas) of the human adrenal cortex.
Conditions of incubation. The adrenal tumor tissue was placed on ice, trimmed from fat and connecting tissue and cut into slices. Slices were incubated during 30 min at 37 °C in 1 ml of Krebs-Ringer phosphate buffer (pH 7.6) containing 2 mmol/l CaCl 2 , 20 mmol/l HEPES, 2 mg/ml BSA and 0-8,5 mmol/l KCl. At the end of incubation tubes were cooled.
Western blotting. The tissue was homogenized in 200 µl of the lysis buffer containing a cocktail of protease and phosphatase inhibitors, homogenate were centrifuged for 15 min at 15,000 g and stored at -60 °C until use. Protein concentration was determined according to Bradford [11] . Protein samples were boiled in the sample buffer (100 mmol/l Tris-HCl, 4% sodium dodecyl sulfate, 0.2% bromophenol blue, 20% glycerol, 10% dithiothreitol) and separated by SDS-PAGE 9% gels [12] . 30 µg of protein were applied per each lane. Proteins were transferred onto nitrocellulose membranes Hybond-C (Amersham Life Science, UK) by semidry blotting. Membranes were blocked with Tris-buffered saline/0.1% Tween 20 containing 5% nonfat dry milk and incubated with primary antibodies for 1 h at RT. After washing three times with Tris-buffered saline/0.1% Tween 20, the blots were incubated with horseradish peroxidase-conjugated species-specific secondary antibody for 1 h at room temperature and then were again washed three times. Complexes were visualized using the ECL reagents (Amersham Life Science, UK). As loading control β-actin was used. X-ray films were photographed by a digital video plex c-Jun, or heterodimer c-Jun/JunB. The level of two AP-1 transcriptional targets (Bim and FasL) was also increased [16] .
Using the Western blotting method a translocation of protein kinase C (PKC)α from cytosol to membranes was showed after adrenal tissue preincubation in the medium with increased K + content (8.5 mmol/l). The translocation means an activation of the enzyme. After incubation of slices in a medium without potassium, the activity of PКC in the microsomes decreases, compared to the activity at the physiological concentration of potassium ions (3.5 mmol/l). [1] . On the other hand, PKC is a regulator of transcription factor АР-1 which play the role on steroidogenesis regulation and c-Fos is a member of the activator protein-1 (AP-1) family of transcription factors.
Thus, a decrease in the expression of transcription factor c-Fos in the potassium ions free incubation medium may indicate the involvement of c-Fos in the inhibitory mechanisms of aldosterone synthesis in adrenocorticocytes with potassium concentrations below physiological parameters.
It was shown that the rise of K + concentration to 5.5-11 mmol/l caused intensification of DNA laddering in conventionally normal human adrenal tissue. On the contrary, the high K + concentration (elevated) decreases the intensity of DNA laddering in tumor tissues [1] . We can conclude that MAPK/c-Fos activation does not represent the mechanisms responsible for such difference.
The results presented here demonstrate that K + can have a direct effect on the expression level of nuclear transcription factor c-Fos in the human aldosteroma tissues. This is evidence for involving MAPK to mediate K + effects in adrenocorticocytes. However, the mechanisms of c-Fos-cellular signaling remain unclear. Therefore, further studies should be performed to identify c-Fos target genes in the human adrenal cortex.
Conclusions
The results of study suggest that K + can have a direct effect on the expression level of nuclear transcription factor c-Fos in tissues from human aldosteromas. 
